News Release

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 9/10/24 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 9/10/24

LUCA Science Publishes Groundbreaking Research in Nature Metabolism: Mitochondria Transfer-Based Therapies Reduce the Morbidity and Mortality of Leigh Syndrome

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 5/18/23 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 5/18/23

Notice of Establishment of Board of Statutory Auditors

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 6/6/22 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 6/6/22

LUCA Science Raises ¥3.86 Billion ($30.3 Million) in Oversubscribed Series B Financing

LUCA Science announced the closing of a ¥3.86 Billion ($30.3 Million) Series B financing.

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 5/2/22 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 5/2/22

Announcement of establishment of CMC laboratory and appointment of Head of CMC

LUCA Science has opened its own CMC research laboratory in Tokyo, and is pleased to announce that Tomoyuki Inoue has been appointed as Head of CMC.

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 4/7/21 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 4/7/21

Subsidiary in the UK and Expansion on the Collaboration With the University of Oxford on the Development of Novel Mitochondrial Therapeutics

LUCA Science has announced the expansion of its international operations, with the establishment of a new wholly-owned subsidiary company in the UK.

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 3/5/21 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 3/5/21

LUCA Science announces joint research and development with four universities on new mitochondrial therapy for COVID-19 Acute Respiratory Distress Syndrome (ARDS) supported by AMED Grants

LUCA Science applied to the 5th call of “Medical Research and Development Innovation Infrastructure Creation Project (CiCLE)” proposals supported by Japan Agency for Medical Research and Development.

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 12/9/20 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 12/9/20

LUCA Science Announces Scientific Advisor Appointment of Prof. Joanna Poulton and Congratulations to Prof. Manu Vatish who has been awarded a full professor title

LUCA Science Inc. is honoured to announce that Prof. Joanna Poulton, at the University of Oxford, has agreed to become a scientific advisor.

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 12/1/20 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 12/1/20

LUCA Science Announces Joint Research With Division of Cardiology, Nagoya University Graduate School of Medicine on the Development of Mitochondrial Therapy

LUCA Science announced that it will collaborate With Division of Cardiology, Nagoya University on the Development of Mitochondrial Therapy for Myocardial Infarction.

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 10/1/20 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 10/1/20

Announcement of the Appointment of Head of Research & LUCA Laboratory

LUCA Science Inc. announces that Dr. Hisashi Ohta has been appointed as Head of Research & LUCA Laboratory at our Hokkaido university campus.

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 9/12/20 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 9/12/20

LUCA Science Announces Joint Research with the University of Oxford, Nuffield Department of Women's & Reproductive Health

LUCA Science announced that it will collaborate with the University of Oxford’s Nuffield Department of Women's & Reproductive Health, in joint research for the treatment of IUGR.

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 9/1/20 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 9/1/20

LUCA Science Announces $9.8 Million Series A Financing to Support Research and Development of Functional Mitochondria as Therapeutic Agents

LUCA Science announced the closing of a $9.8 million Series A financing.

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 7/1/20 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 7/1/20

Announcement of New CEO

LUCA Science announced that Dr. Rick C. Tsai will become the new Chief Executive Officer (CEO) of the company, effective July 1, 2020.

ルカ・サイエンス株式会社ルカ・サイエンス株式会社 4/1/20 ルカ・サイエンス株式会社ルカ・サイエンス株式会社 4/1/20

Establishment of LUCA laboratory at the Hokkaido University Campus.

LUCA Science concluded a joint research agreement with Hokkaido University on April 1, 2020 to establish a program for industry creation, the "Laboratory for Biological Drug Development based on DDS Technology"

Contact